GOVX
GeoVax Labs, Inc.NASDAQHealthcare$1.33-6.01%ClosedMarket Cap: $1.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.21
P/S
0.38
EV/EBITDA
0.15
DCF Value
$18.28
FCF Yield
-1913.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.3%
Operating Margin
-761.6%
Net Margin
-754.7%
ROE
-489.7%
ROA
-376.0%
ROIC
-520.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | -Infinity% | $-6.4M | $-6.3M | $-7.75 | — |
| Q2 2025 | $852.3K | 100.0% | $-5.4M | $-5.4M | $-8.75 | — |
| Q1 2025 | $1.6M | 99.0% | $-5.4M | $-5.4M | $-11.25 | — |
| Q4 2024 | $864.4K | 97.5% | $-8.3M | $-8.3M | $-19.50 | — |
| FY 2024 | $4.0M | 97.6% | $-25.1M | $-25.0M | $-120.50 | — |
| Q3 2024 | $2.8M | 100.0% | $-5.9M | $-5.8M | $-22.75 | — |
| Q2 2024 | $300.7K | 100.0% | $-5.1M | $-5.1M | $-49.75 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.9M | $-5.9M | $-57.50 | — |
| Q4 2023 | $0.00 | -Infinity% | $-7.7M | $-7.6M | $-74.75 | — |
| FY 2023 | $0.00 | -Infinity% | $-26.7M | $-26.0M | $-255.50 | — |
| Q3 2023 | $0.00 | -Infinity% | $-8.6M | $-8.4M | $-82.75 | — |
| Q2 2023 | $0.00 | -Infinity% | $-6.2M | $-5.9M | $-58.25 | — |